Cargando…
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study
BACKGROUND: Contrary to the minimal criteria proposed by the International Society for Cell and Gene Therapy for defining multipotent mesenchymal stromal cells (MSC), human leukocyte antigen (HLA)-DR expression is largely unpredictable in ex vivo-expanded clinical-grade cultures. Although activation...
Autores principales: | Grau-Vorster, Marta, Laitinen, Anita, Nystedt, Johanna, Vives, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567533/ https://www.ncbi.nlm.nih.gov/pubmed/31196185 http://dx.doi.org/10.1186/s13287-019-1279-9 |
Ejemplares similares
-
A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells
por: Laitinen, Anita, et al.
Publicado: (2015) -
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019) -
Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
por: Mirabel, Clémentine, et al.
Publicado: (2018) -
Off-the-shelf mesenchymal stromal cells derived from umbilical cord tissue
por: Oliver-Vila, Irene, et al.
Publicado: (2015) -
The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes
por: Oja, Sofia, et al.
Publicado: (2019)